Clinical trial
Efficacy of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair
NCT05705024 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Locally Delivered Allogeneic Mesenchymal Stem Cells for Promoting Corneal Repair
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 29, 2023
- Completion date
- September 28, 2026
- Enrollment
- 38 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.